ArticleCancer gene therapy2025

Targeting mTORC2 in lung squamous cell carcinoma improves anti-tumor immunity through the PSGL-1-VISTA axis.

Verra M Ngwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.